Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-6080717

  • Global Smart Insulin Pens Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast 2017 – 2023

  • Publish: July 2017 | Report Code: HME-6080717

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

Smart insulin pen is an injection delivery device. Smart insulin is a device that can automatically manages blood sugar levels. Moreover, Smart Insulin device also keep the blood sugar level in normal range in diabetic. The increasing adoption of medical management process is boosting the growth in global smart insulin pens market with a CAGR of around 18%. The is growing concern for patient care across medical facilities is one of the key factor that is rising the adoption of medical management process across the globe. Hence, the increasing adoption of medical management process in the world is opening new avenues for smart insulin pens market.

The rising prevalence of diabetes across the globe is one of the major factor that is driving the growth of smart insulin pens globally. According to World Bank around 8.5% of world population is living from any kind of diabetes globally in 2016. Moreover, according to international federation of diabetes, globally around 415 million people are suffering from diabetes in 2015. It is expected that by the end of 2040 there are around 642 million people in the world who suffers from any kind of diabetes. Globally, diabetes has also emerged as one of the major cause for deaths.  According to international diabetes federation, in 2015, around 5 million people die from diabetes in the world. Hence, the rising prevalence of diabetes globally is boosting growth in global smart insulin pens market. Despite of driving factors such as lack of dose flexibility and privacy and security concerns associated with patient data are major challenges that are restricting the growth of the global smart insulin pens market.

Source: OBRC Analysis

The report on global smart insulin pens market includes connectivity, indication and channel.

Disease indication where smart insulin pens applied are:

  • Type 1 diseases
  • Type 2 diseases



Smart insulin pens by connectivity include:

  • Bluetooth connected smart insulin pens
  • USB connected smart insulin pens



Channel through which smart insulin pens are distributed includes:

  • Clinics & Ambulatory Surgical Centers
  • E-Commerce
  • Retail Pharmacies




The report scope is widely categorized on the basis of its connectivity through which smart insulin pens are connected which include Bluetooth connected smart insulin pens and USB connected smart insulin pens. Moreover, the market revenue estimates and forecast includes insulin pens. However, report scope excludes syringes and other traditional insulin.

The global smart insulin pens market report has been geographically segmented in:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America accounts highest revenue share in 2016. The rising prevalence of diabetes in North American countries (U.S. & Canada) is contributing towards the growth of North America smart insulin pens market. According to CDC, around 29 million people are suffering from diabetes in the North America Region which contribute around 9.3% of total U.S. population in 2015. In this 29 million people, around 21 million are diagnosed and get treatment for the diabetes, whereas as around 8 million are still undiagnosed who are not getting any kind of treatment for diabetes.  Furthermore, the major part of diabetic population in U.S are generally of age 35 and above, which accounted for 24.6 million in 2015. However, around 4.4 million dietetic people are aged 0 to 35 years. Moreover, In United States around 1.25 million children are suffering from diabetes in 2015. Hence, the rising prevalence diabetes in North American countries is contributing towards the growth of North America smart insulin pens market. Furthermore, Asia Pacific is the fastest growing region in global smart insulin pens market. The growth in Asia Pacific smart insulin pens market is mainly driven by the increasing prevalence of diabetes in Asian countries such as India, China, Japan, etc. According to world bank, in India around 9.3% of total population suffers from diabetes in 2015. Whereas in China around 9.8% of total population is living with diabetes in 2015. Japan has the lowest rate of the diabetes in Asian countries which is around 5.7% of total population suffers from diabetes in Japan. The low prevalence of diabetes in Japan is the key factor due to which Japan is experiencing low growth as compared to India and China.

Global smart insulin pens market report covers segmentation analysis of connectivity, indication and channel. Report further covers segments of indication which includes type of diabetes such as Type 1 diabetes and Type 2 diabetes.  Type 2 diabetes held the largest revenue share in indication segment due to higher adoption of smart insulin pens by type 2 diabetes patients.

The major market players of the global smart insulin pens market are:

  • ABBOTT (U.S.)
  • COMPANION MEDICAL INC. (U.S.)
  • ELLI LILLY (U.S.)
  • EMPERRA GMBH (GERMANY)
  • MEDTRONIC’S (U.S.)
  • JIANGSU DELFU MEDICAL DEVICE CO. (CHINA)
  • OTHERS








These companies using various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, new product development and FDA approval is the key strategy adopted by the companies in the smart insulin pens market.

For Example; On August 2016, Emperra GmBH launched Bluetooth insulin pen named ESYSTA BT pen. The BT pen allows to wireless data transfer with 868 MHz which helps to enhance diabetes management. Similarly, on August 2016, Companion Medical got FDA 510 (k) approval for company mobile application and wireless InPen insulin pen, which contains computer chip technology with Bluetooth LE wireless capabilities.

The report covers detailed analysis of companies which comprises of overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in smart insulin pens market.

Key reason to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023
  • Report includes detailed analysis of different segments such as connectivity, indication and channel through which smart insulin pens distributed.
  • Identify, understand, and the strength, opportunities, challenges and threat of the smart insulin pens market.
  • Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, competitive landscape analysis of major players of voice communication segment market.
  • Contains detailed analysis of FDA approval for smart insulin pens in 2015, 2016 and 2017.
  • Detailed analysis of various the regulatory policies which are affecting the global smart insulin pens market.







How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global smart insulin pens market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis, return on investment analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report contains detailed patent analysis and FDA approval for smart insulin pens during 2015-2017. The report discusses competitive landscape of the smart insulin pens market, with giving extensive SCOT analysis of key companies. 

Key Findings of the global smart insulin pens market.

  • Increasing adoption of medical management process is boosting growth in global smart insulin pens market.
  • North America held highest revenue share in 2016.
  • Bluetooth connected smart insulin pens held the large revenue share in 2016 due to rising demand for automated data sharing with healthcare providers.
  • New product development and FDA approval is the key strategy adopted by players of smart insulin pens market.  
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL SMART INSULIN PENS MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. PATENT ANALYSIS
2.7.5. SEE-SAW ANALYSIS
2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. RISING PREVALENCE OF DIABETES 
3.1.2. RISING DEMAND FOR DIABETES MANAGEMENT 
3.1.3. EXPLOSION OF BLUETOOTH CONNECTED INSULIN PEN
3.2. MARKET RESTRAINTS
3.2.1. PRIVACY AND SECURITY CONCERNS
3.2.2. LACK OF DOSE FLEXIBILITY
3.3. MARKET OPPORTUNITIES
3.3.1. NEEDLE STICK INJURIES 
3.3.2. INCREASING ADOPTION OF MEDICAL MANAGEMENT PROCESS
3.3.3. GROWING DEMAND FOR PERSONALIZED OR PATIENT CENTRIC DEVICES
3.4.  MARKET CHALLENGES 
3.4.1. HIGH COST OF SMART PENS
3.4.2. LOW ACCURACY CONCERNS 
 
4. MARKET SEGMENTATION 
4.1. GLOBAL SMART INSULIN PENS MARKET BY CONNECTIVITY
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL BLUETOOTH CONNECTED SMART INSULIN PEN MARKET
4.1.5.1.1. APPLICATION
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.2. GLOBAL USB CONNECTED SMART INSULIN PEN MARKET
4.1.5.2.1. APPLICATION
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.1.5.2.5. KEY CONCLUSIONS
4.2. GLOBAL SMART INSULIN PENS MARKET BY INDICATION
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL TYPE 1 DIABETES MARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL TYPE 2 DIABETES MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.2.5. KEY CONCLUSIONS
4.3. GLOBAL SMART INSULIN PENS MARKET BY CHANNEL
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL CLINICS AND AMBULATORY SURGICAL CENTERS MARKET
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL E-COMMERCE MARKET
4.3.5.2.1. APPLICATION
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.3.5.2.5. KEY CONCLUSIONS
4.3.5.3. GLOBAL RETAIL PHARMACIES MARKET
4.3.5.3.1. APPLICATION
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS 
4.3.5.3.5. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITION 
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL SMART INSULIN PENS MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRIAL END-USER ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. ABBOTT
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES 
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. COMMON SENSE INC.
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES 
7.2.5. SCOT ANALYSIS 
7.2.6. STRATEGIC ANALYSIS
7.3. COMPANION MEDICAL INC
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES 
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS
7.4. DEXCOM
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES 
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. DIABNEXT
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES 
7.5.5. SCOT ANALYSIS 
7.5.6. STRATEGIC ANALYSIS
7.6. DIGITAL MEDICS PTD LTD
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES 
7.6.5. SCOT ANALYSIS 
7.6.6. STRATEGIC ANALYSIS
7.7. ELLI LILLY
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES 
7.7.5. SCOT ANALYSIS 
7.7.6. STRATEGIC ANALYSIS
7.8. EMPERRA GMBH
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES 
7.8.5. SCOT ANALYSIS 
7.8.6. STRATEGIC ANALYSIS
7.9. INNOVATION ZED
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES 
7.9.5. SCOT ANALYSIS 
7.9.6. STRATEGIC ANALYSIS
7.10. MEDTRONIC’S
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES 
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11. PENDIQ GMBH
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES 
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. SANOFI
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES 
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. SMARTPLUS
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES 
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. TANDEM DIABETES CARE
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES 
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. OTHERS
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES 
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL SMART INSULIN PENS MARKET BY CONNECTIVITY 2014-2023 ($ MILLION)
2. GLOBAL BLUETOOTH CONNECTED SMART INSULIN PEN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL USB CONNECTED SMART INSULIN PEN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL SMART INSULIN PENS MARKET BY INDICATION 2014-2023 ($ MILLION) 
5. GLOBAL TYPE 1 DIABETES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION) 
6. GLOBAL TYPE 2 DIABETES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION) 
7. GLOBAL SMART INSULIN PENS MARKET BY CHANNEL 2014-2023 ($ MILLION)
8. GLOBAL CLINICS AND AMBULATORY SURGICAL CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL E-COMMERCE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL RETAIL PHARMACIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. NORTH AMERICA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
12. EUROPE SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
13. ASIA PACIFIC SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
14. REST OF THE WORLD SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL BLUETOOTH CONNECTED SMART INSULIN PEN MARKET 2014-2023 ($ MILLION)
2. GLOBAL USB CONNECTED SMART INSULIN PEN MARKET 2014-2023 ($ MILLION)
3. GLOBAL TYPE 1 DIABETES MARKET 2014-2023 ($ MILLION)
4. GLOBAL TYPE 2 DIABETES MARKET 2014-2023 ($ MILLION)
5. GLOBAL CLINICS AND AMBULATORY SURGICAL CENTERS MARKET 2014-2023 ($ MILLION)
6. GLOBAL E-COMMERCE MARKET 2014-2023 ($ MILLION)
7. GLOBAL RETAIL PHARMACIES MARKET 2014-2023 ($ MILLION) 
8. UNITED STATES (U.S.) SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
9. CANADA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
10. UNITED KINGDOM (UK) SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
11. FRANCE SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
12. GERMANY SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
13. SPAIN SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
14. ROE SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
15. INDIA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
16. CHINA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
17. JAPAN SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
18. AUSTRALIA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
19. ROAPAC SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
20. LATIN AMERICA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
21. MENA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion